# Matinas Biopharma (MTNB) — Earnings

MTNB · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/mtnb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2024 |
| Period end | Sep 30, 2024 |
| EPS actual | −$12.75 |
| EPS estimate | −$15.83 |
| EPS surprise | +19.43% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 13, 2024 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1582554/000149315224045201/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2024 | Nov 13, 2024 | −$15.83 | −$12.75 | 19.43% | — | — |
| Q2 2024 | Aug 14, 2024 | −$18.75 | −$15.00 | 20.00% | — | — |
| Q1 2024 | May 9, 2024 | −$22.50 | −$22.50 | 0.00% | — | — |
| Q4 2023 | Mar 27, 2024 | −$22.50 | −$15.00 | 33.33% | $300,000.00 | — |
| Q3 2023 | Nov 8, 2023 | −$21.79 | −$22.50 | -3.27% | $300,000.00 | — |
| Q2 2023 | Aug 9, 2023 | −$22.76 | −$22.50 | 1.15% | $300,000.00 | — |
| Q1 2023 | May 10, 2023 | −$22.50 | −$22.50 | 0.00% | $300,000.00 | $1.1M |
| Q4 2022 | Mar 15, 2023 | −$18.98 | −$15.00 | 20.95% | $1.0M | $1.1M |
| Q3 2022 | Nov 2, 2022 | −$22.26 | −$22.50 | -1.09% | $1.1M | $1.1M |
| Q2 2022 | Aug 11, 2022 | −$25.22 | −$22.50 | 10.78% | $83,333.00 | $1.1M |
| Q1 2022 | May 12, 2022 | −$20.00 | −$22.50 | -12.50% | $2,778.00 | — |
| Q4 2021 | Mar 8, 2022 | −$25.33 | −$22.50 | 11.18% | $450,000.00 | — |
| Q3 2021 | Nov 8, 2021 | −$14.59 | −$22.50 | -54.24% | $2.0M | — |
| Q2 2021 | Aug 10, 2021 | −$22.50 | −$15.00 | 33.33% | $25,000.00 | — |
| Q1 2021 | May 10, 2021 | −$19.76 | −$22.50 | -13.85% | $25,000.00 | $33,333.00 |
| Q4 2020 | Mar 29, 2021 | −$20.90 | −$22.50 | -7.68% | $1.3M | $62,500.00 |
| Q3 2020 | Nov 6, 2020 | −$26.25 | −$22.50 | 14.29% | $24,536.00 | $96,000.00 |
| Q2 2020 | Aug 10, 2020 | −$24.00 | −$22.50 | 6.25% | $24,491.00 | — |
| Q1 2020 | May 11, 2020 | −$24.00 | −$22.50 | 6.25% | $26,200.00 | — |

## Frequently Asked Questions

### When did Matinas Biopharma (MTNB) last report earnings?

Matinas Biopharma last reported on Nov 13, 2024, covering fiscal Q3 2024.

### Did MTNB beat earnings estimates?

Yes. Matinas Biopharma reported EPS of −$12.75 for Q3 2024 against a −$15.83 estimate — a 19.43% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).